A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of the AL3810 in the Treatment of Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors
- Status
- COMPLETED
- Phase
- PHASE1
MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Talazoparib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Intralesional Administration of MK-4621 (RGT100) in Adult Participants With Advanced or Recurrent Tumors (MK-4621-001/RGT100-001)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Pharmacokinetics and Safety Study of Talazoparib
- Status
- COMPLETED
- Phase
- PHASE1
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
- Status
- TERMINATED
- Phase
- PHASE1
Study of Samalizumab in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of TAS-116 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SC10914 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1